The Next Generation CRO

“Pivotal was an invaluable partner in our Non-Muscle Invasive Bladder Cancer (NMIBC) gene therapy study. Their team continued to demonstrate exceptional efficiency during feasibility and start-up as well as trial´s implementation. I was particularly impressed by their strategic and tactical thinking and proactive handling of blocks. I would highly recommend Pivotal to any biotech seeking a reliable and capable CRO partner.”

The team at Pivotal operates as a seamless extension of our internal team, building trust with our European clinical trial sites and our confidence in our ability to execute high-quality clinical trials. The Pivotal management team acts as a true partner, equally focused on our objectives to develop innovative therapeutic treatments to patients with serious unmet medical needs.

Pivotal continues to be my CRO of choice. They complement our existing team by providing functional area expertise that we do not currently possess. Their personnel are highly engaged, and proficient in what they do. Pivotal’s leadership team is experienced and, more importantly, incredibly engaged throughout the entire study. These are some of the reasons Pivotal continues to be a trusted partner for us.

We have worked with Pivotal for more than 4 years now. During this time, Pivotal´s team has been able to accommodate all our specific needs, always providing the right services. They are easily accessible and very dedicated to making things work. Undoubtedly, Pivotal is a key partner for us in the clinical development of our asset.

I have worked with Pivotal on two studies and have been particularly impressed with the care they give studies, their personal attention to the needs of sponsors, and their dedication to getting things right. Pivotal is a closely knit group. There is no bureaucracy, simply the dedication to serving the needs of their biotech clients. They are the closest thing I can find to having my company personnel on the ground in Spain and Europe.

I have been working with Pivotal since 2014 on 6 projects in GU tumors and what I have encountered is a dedicated team to clinical research, very much attentive to the detailed needs of independent investigators, responsiveness and quality-minded throughout. Pivotal is my favorite CROs to work with and have no hesitation to recommend for any new trials in Oncology and beyond.